CellSeed Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Public

  • Employees
  • 44

Employees

  • Stock Symbol
  • 7776

Stock Symbol

  • Share Price
  • $1.64
  • (As of Monday Closing)

CellSeed General Information

Description

CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Stock Exchange
TKS
Corporate Office
  • Telecom Center Building
  • 2-5-10, Aomi, Koto-ku
  • Tokyo, 135-0064
  • Japan

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellSeed Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.64 $1.50 $1.39 - $7.52 $51.6M 31.5M 540K -$0.21

CellSeed Financials Summary

In Thousands,
USD
TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 60,786 23,035 19,157 24,694
Revenue 1,134 962 1,472 1,868
EBITDA (5,707) (8,248) (7,213)
Net Income (5,542) (5,781) (8,313) (7,341)
Total Assets 17,676 11,775 12,238 17,516
Total Debt 1,025 1,211 1,390 1,551
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CellSeed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CellSeed‘s full profile, request access.

Request a free trial

CellSeed Patents

CellSeed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022088467-A Cell culture equipment for cell sheet production, recovery support, and cell sheet production kit Pending 02-Dec-2020 0000000000
JP-7053065-B1 Cell culture equipment for cell sheet production, recovery support, and cell sheet production kit Active 02-Dec-2020 0000000000 0
JP-2022087900-A Cell culture device for producing cell sheet, recovery support, and kit for producing cell sheet Active 02-Dec-2020 0000000000
EP-4257668-A1 Cell culture device for producing cell sheet, kit for producing cell sheet and method for producing cell sheet Pending 02-Dec-2020 0000000000
US-20240010963-A1 Cell culture device for producing cell sheet, kit for producing cell sheet and method for producing cell sheet Pending 02-Dec-2020 C12M33/00
To view CellSeed’s complete patent history, request access »

CellSeed Executive Team (5)

Name Title Board Seat Contact Info
Setsuko Hashimoto Chief Executive Officer, President & Board Member
Teruo Okano Ph.D Founder & Board Member
Yukio Hasegawa Ph.D Owner
You’re viewing 3 of 5 executive team members. Get the full list »

CellSeed Board Members (4)

Name Representing Role Since
Setsuko Hashimoto CellSeed Chief Executive Officer, President & Board Member 000 0000
Teruo Okano Ph.D CellSeed Founder & Board Member 000 0000
You’re viewing 2 of 4 board members. Get the full list »

CellSeed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CellSeed Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CellSeed‘s full profile, request access.

Request a free trial

CellSeed ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view CellSeed’s complete esg history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »